Clinical Trials Logo

Respiratory Infection Other clinical trials

View clinical trials related to Respiratory Infection Other.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03749226 Terminated - Clinical trials for Ventilator Associated Pneumonia

Nebulized Aztreonam for Prevention of Gram Negative Ventilator-associated Pneumonia

AZLIS
Start date: March 19, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Aerosol antibiotic administration offers the theoretical advantages of achieving high drug concentration at the infection site and low systemic absorption, thereby avoiding toxicity. Antibiotic aerosolization has good results in patients with cystic fibrosis, but data are scarce for patients under mechanical ventilation. Prospective, randomized 1:1, open-label study to assess the microbiological cure and pharmacokinetics (PK), safety and efficacy of nebulized Aztreonam lysine (75 mg dose) each 8 hr during 5 days in ventilated patients heavily colonized by Gram-negative bacteria. It is planned to include a total of 20 ventilated patients heavily colonized. Only ten of them (active group) will receive 5 days of treatment with nebulized AZLI.The control group will not receive treatment.